title: PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer.
authors.affiliation: Nuclear Medicine, S.Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy. francesco.ceci@studio.unibo.it.|UO Medicina Nucleare PAD. 30, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola-Malpighi, Via Massarenti, 9, 40138, Bologna, Italy. francesco.ceci@studio.unibo.it.
authors.forename: Francesco
authors.initials: F
authors.lastname: Ceci
authors.affiliation: Nuclear Medicine, S.Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Castellucci
authors.affiliation: Nuclear Medicine, S.Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Nanni
authors.affiliation: Nuclear Medicine, S.Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Fanti
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008297:Male; D017063:Outcome Assessment, Health Care / Q000379:methods*; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D000970:Antineoplastic Agents